The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
LRP in Amyloid‐β Production and Metabolism
Abstract
Amyloid‐β peptide (Aβ) production and accumulation in the brain is a central event in the pathogenesis of Alzheimer's disease (AD). Recent studies have shown that apolipoprotein E (apoE) receptors, members of the low‐density lipoprotein receptor (LDLR) family, modulate Aβ production as well as Aβ cellular uptake. Aβ is derived from proteolytic processing of the amyloid precursor protein (APP), which interacts with several members of the LDLR family. Studies from our laboratory have focused on two members of the LDLR family, the LDLR‐related protein (LRP) and LRP1B. Our in vitro studies have shown that while LRP's rapid endocytosis facilitates APP endocytic trafficking and processing to Aβ, LRP1B's slow endocytosis inhibits these processes. In addition to modulating APP endocytic trafficking, LRP's rapid endocytosis also facilitates Aβ cellular uptake by binding to Aβ either directly or via LRP ligands such as apoE. Our in vivo studies using transgenic mice have shown that overexpression of LRP in central nervous system (CNS) neurons increases soluble brain Aβ and this increase correlates with deficits in memory. Together our studies demonstrate that members of the LDLR family modulate APP processing and Aβ metabolism by several independent mechanisms. Understanding the pathways that modulate brain Aβ metabolism may enable the rational design of molecular medicine to treat AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a shift from cytoplasmic to cell surface expression of these receptors may precede the up-regulation induced by only high levels of A. 46”
From Lipoprotein Receptor-Related Protein-1 Mediates Amyloid-β-Mediated Cell Death of Cerebrovascular Cells (2007) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J.-C., Paul, S. M., & Holtzman, D. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151261398 · Cited by 1,298
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294
Research works printed but not linked: 110
- 10.1016/0006-8993(91)91553-D · DOI · Paper page
- 10.1523/JNEUROSCI.13-04-01676.1993 · DOI · Paper page
- 10.1073/pnas.91.25.12243 · DOI · Paper page
- 10.1021/jm00021a001 · DOI
- 10.1126/science.282.5391.1075 · DOI · Paper page
- 10.1016/S0140-6736(95)92053-6 · DOI · Paper page
- 10.1038/nm0198-097 · DOI · Paper page
- 10.1074/jbc.274.10.6483 · DOI · Paper page
- 10.1523/JNEUROSCI.20-11-04050.2000 · DOI · Paper page
- 10.1016/0304-3940(96)12717-8 · DOI
- 10.1046/j.1471-4159.1997.69052048.x · DOI
- 10.1016/S0304-3940(99)00273-6 · DOI
- 10.1016/S1357-4310(99)01508-7 · DOI
- 10.1073/pnas.96.7.3342 · DOI · Paper page
- 10.1002/ana.1042 · DOI
- 10.1038/nn0901-859 · DOI
- 10.1074/jbc.271.34.20631 · DOI · Paper page
- 10.1016/S0925-4439(00)00030-2 · DOI
- 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
- 10.1523/JNEUROSCI.19-20-08876.1999 · DOI · Paper page
- 10.1126/science.1072994 · DOI · Paper page
- 10.1172/JCI200317527 · DOI
- 10.1097/00001756-200301200-00023 · DOI · Paper page
- 10.1016/j.neuron.2005.02.013 · DOI
- 10.1016/j.neurobiolaging.2004.02.027 · DOI · Paper page
- 10.1016/j.neurobiolaging.2004.09.018 · DOI · Paper page
- 10.1016/S0002-9440(10)63185-9 · DOI · Paper page
- 10.1152/physrev.2001.81.2.741 · DOI · Paper page
- 10.1172/JCI0216783 · doi:10.1172/jci0216783 · Paper page
- 10.1016/S0896-6273(00)00051-9 · DOI · Paper page
- 10.1016/S0896-6273(02)00585-8 · DOI
- 10.1146/annurev.neuro.26.041002.131334 · DOI · Paper page
- 10.1126/science.1096187 · DOI · Paper page
- 10.1016/S0021-9258(17)32449-3 · DOI · Paper page
- 10.1242/jcs.109.5.991 · DOI · Paper page
- 10.1074/jbc.270.8.3565 · DOI · Paper page
- 10.1046/j.1471-4159.2000.741131.x · DOI
- 10.1074/jbc.274.27.18851 · DOI · Paper page
- 10.1074/jbc.274.51.36801 · DOI · Paper page
- 10.1074/jbc.M304009200 · DOI · Paper page
- 10.1021/bi9906827 · DOI · Paper page
- 10.1002/j.1460-2075.1988.tb03306.x · DOI · Paper page
- 10.1126/science.2786251 · DOI · Paper page
- 10.1073/pnas.91.21.9725 · DOI · Paper page
- 10.1073/pnas.89.19.9252 · DOI · Paper page
- 10.1006/geno.1997.4702 · DOI · Paper page
- 10.1074/jbc.271.40.24761 · DOI · Paper page
- 10.1093/oxfordjournals.jbchem.a022223 · DOI · Paper page
- 10.1016/S0378-1119(98)00311-4 · DOI · Paper page
- 10.1006/bbrc.1998.9061 · DOI · Paper page
- Liu C.X., 2000, LRP‐DIT, a putative endocytic receptor gene, is frequently inactivated in non‐small cell lung cancer cell lines, Cancer Res., 60, 1961
- 10.1385/MN:23:1:53 · DOI · Paper page
- 10.1038/88556 · DOI
- 10.1097/00041433-199804000-00012 · DOI
- 10.1002/j.1460-2075.1995.tb07221.x · DOI · Paper page
- 10.1074/jbc.271.36.22218 · DOI · Paper page
- 10.1016/S1050-1738(00)00045-1 · DOI
- 10.1097/00041433-200004000-00009 · DOI · Paper page
- 10.1016/S0896-6273(01)00234-3 · DOI · Paper page
- 10.1016/S0092-8674(00)80782-5 · DOI · Paper page
- 10.1038/35035124 · DOI · Paper page
- 10.1038/35035117 · DOI · Paper page
- 10.1038/35035110 · DOI · Paper page
- 10.1074/jbc.273.50.33556 · DOI · Paper page
- 10.1128/MCB.19.7.5179 · DOI · Paper page
- 10.1042/bj3470613 · DOI · Paper page
- 10.1146/annurev.bi.63.070194.003125 · DOI · Paper page
- 10.1172/JCI200113992 · DOI · Paper page
- 10.1002/j.1460-2075.1990.tb08301.x · DOI · Paper page
- 10.1016/0092-8674(92)90511-A · DOI · Paper page
- 10.1016/0092-8674(93)90130-I · DOI · Paper page
- 10.1042/bj3360381 · DOI · Paper page
- 10.1523/JNEUROSCI.20-02-00542.2000 · DOI · Paper page
- 10.1006/abbi.1999.1521 · DOI
- 10.1073/pnas.200238297 · DOI · Paper page
- 10.1074/jbc.M204426200 · DOI
- 10.1074/jbc.M200427200 · DOI · Paper page
- 10.1074/jbc.M200428200 · DOI · Paper page
- 10.1074/jbc.M000490200 · DOI · Paper page
- 10.1128/MCB.21.4.1185-1195.2001 · DOI
- 10.1016/S0021-9258(19)39742-X · DOI · Paper page
- 10.1074/jbc.M101589200 · DOI · Paper page
- 10.1074/jbc.M102727200 · DOI
- 10.1073/pnas.90.5.1977 · DOI · Paper page
- 10.1126/science.8346443 · DOI · Paper page
- 10.1212/WNL.45.6.1092 · DOI · Paper page
- 10.1016/S0140-6736(96)09328-2 · DOI · Paper page
- 10.1016/S0140-6736(00)03155-X · DOI · Paper page
- 10.1083/jcb.200207113 · DOI · Paper page
- 10.1023/A:1023294820218 · DOI
- 10.1002/ana.410370212 · DOI · Paper page
- 10.1016/0006-8993(96)00384-8 · DOI
- 10.1016/S0169-328X(02)00203-6 · DOI · Paper page
- 10.1212/WNL.49.1.56 · DOI · Paper page
- 10.1016/S0304-3940(97)13381-X · DOI
- 10.1038/1243 · DOI · Paper page
- 10.1016/0092-8674(95)90320-8 · DOI · Paper page
- 10.1016/S0006-8993(96)00711-1 · DOI
- 10.1523/JNEUROSCI.5451-03.2004 · DOI · Paper page
- 10.1523/JNEUROSCI.21-21-08354.2001 · DOI · Paper page
- 10.1074/jbc.275.10.7410 · DOI · Paper page
- 10.1074/jbc.M500613200 · DOI
- 10.1242/jcs.114.5.899 · DOI · Paper page
- 10.1006/geno.2000.6331 · DOI
- 10.1074/jbc.M207705200 · DOI
- 10.1074/jbc.M313893200 · DOI · Paper page
- 10.1128/MCB.25.21.9259-9268.2005 · DOI · Paper page
- 10.1073/pnas.0503689102 · DOI · Paper page
- 10.1523/JNEUROSCI.3882-05.2006 · DOI · Paper page
- 10.1523/JNEUROSCI.4946-05.2006 · DOI · Paper page
Cited by
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
The Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
The Many Substrates of Presenilin/γ-Secretase
Haapasalo, A., & Kovacs, D. M. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101065 · Cited by 458
Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase Macropinocytosis
Mandrekar, S., Jiang, Q., Lee, C. Y. D., Koenigsknecht-Talboo, J., Holtzman, D. M., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5572-08.2009 · Cited by 415
Molecular Mechanisms of Amyloid Oligomers Toxicity
Kayed, R., & Lasagna-Reeves, C. A. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129001 · Cited by 415
Apolipoprotein E: From lipid transport to neurobiology
Hauser, P. S., Narayanaswami, V., & Ryan, R. O. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.09.001 · Cited by 320
Teasdale, R. D., & Collins, B. M. (2012) · Biochemical Journal · doi:10.1042/bj20111226 · Cited by 281
Kanekiyo, T., Zhang, J., Liu, Q., Liu, C.-C., Zhang, L., & Bu, G. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5491-10.2011 · Cited by 212
Self-citationLRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-β
Kanekiyo, T., Liu, C.-C., Shinohara, M., Li, J., & Bu, G. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3987-12.2012 · Cited by 211
Self-citationMechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease
Yoon, S.-S., & AhnJo, S.-M. (2012) · Biomolecules and Therapeutics · doi:10.4062/biomolther.2012.20.3.245 · Cited by 205
Benoit, M. E., Hernandez, M. X., Dinh, M. L., Benavente, F., Vasquez, O., & Tenner, A. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.400168 · Cited by 155
Genetics ignite focus on microglial inflammation in Alzheimer’s disease
Malik, M., Parikh, I., Vasquez, J. B., Smith, C., Tai, L., Bu, G., LaDu, M. J., Fardo, D. W., Rebeck, G. W., & Estus, S. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0048-1 · Cited by 161
Self-citationWilhelmus, M. M. M., Otte-Höller, I., van Triel, J. J. J., Veerhuis, R., Maat-Schieman, M. L. C., Bu, G., de Waal, R. M. W., & Verbeek, M. M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070050 · Cited by 138
Self-citationLigand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway.
Shi, Y., Mantuano, E., Inoue, G., Campana, W. M., & Gonias, S. L. (2009) · Science Signaling · doi:10.1126/scisignal.2000188 · Cited by 130
ATP-binding cassette transporter A7 (ABCA7) loss of function alters Alzheimer amyloid processing
Satoh, K., Abe-Dohmae, S., Yokoyama, S., St George-Hyslop, P., & Fraser, P. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.655076 · Cited by 128
Marzolo, M.-P., & Bu, G. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.10.005 · Cited by 122
Self-citationAccumulation of intraneuronal Aβ correlates with ApoE4 genotype
Christensen, D. Z., Schneider-Axmann, T., Lucassen, P. J., Bayer, T. A., & Wirths, O. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0666-1 · Cited by 120
Fuentealba, R. A., Liu, Q., Zhang, J., Kanekiyo, T., Hu, X., Lee, J.-M., LaDu, M. J., & Bu, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011884 · Cited by 116
Self-citationFuentealba, R. A., Liu, Q., Kanekiyo, T., Zhang, J., & Bu, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.021030 · Cited by 97
Self-citationFong, L. K., Yang, M. M., dos Santos Chaves, R., Reyna, S. M., Langness, V. F., Woodruff, G., Roberts, E. A., Young, J. E., & Goldstein, L. S. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000441 · Cited by 72
Fuentealba, R. A., Barría, M. I., Lee, J., Cam, J., Araya, C., Escudero, C. A., Inestrosa, N. C., Bronfman, F. C., Bu, G., & Marzolo, M.-P. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-14 · Cited by 70
Self-citationArmato, U., Chiarini, A., Chakravarthy, B., Chioffi, F., Pacchiana, R., Colarusso, E., Whitfield, J. F., & Dal Prà, I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.020 · Cited by 68
Receptor-associated Protein Interacts with Amyloid-β Peptide and Promotes Its Cellular Uptake
Kanekiyo, T., & Bu, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.015032 · Cited by 44
Self-citationThe multifaceted role of WNT signaling in Alzheimer’s disease onset and age-related progression.
Kostes, W. W., & Brafman, D. A. (2023) · Cells · doi:10.3390/cells12081204 · Cited by 43
Transcriptional and post‐transcriptional regulation of β‐secretase
Tamagno, E., Guglielmotto, M., Monteleone, D., Vercelli, A., & Tabaton, M. (2012) · IUBMB Life · doi:10.1002/iub.1099 · Cited by 40
Monomeric Aβ1–42 and RAGE: key players in neuronal differentiation
Piras, S., Furfaro, A. L., Piccini, A., Passalacqua, M., Borghi, R., Carminati, E., Parodi, A., Colombo, L., Salmona, M., Pronzato, M. A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.002 · Cited by 27
Stress-induced upregulation of VLDL receptor alters Wnt-signaling in neurons
Kysenius, K., & Huttunen, H. J. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.01.001 · Cited by 24
Larios, J. A., & Marzolo, M.-P. (2012) · Frontiers in Biology · doi:10.1007/s11515-011-1186-7 · Cited by 9
Metadata
- Authors
- BU, G., CAM, J., & ZERBINATTI, C.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2006-11
- Volume
- 1086
- Issue
- 1
- Pages
- 35-53
- ISSN
- 0077-8923
- 1749-6632
- Cited by
- 114
- References
- 40
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.